Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity
Rushika M. Perera(University of California, San Francisco), Terrance G. Johns(The Kids Research Institute Australia)
Cited by 103
Related Papers
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
|Nature|2015|788
The epidermal growth factor receptor variant <scp>III</scp> (<scp>EGFR</scp>v<scp>III</scp>): where wild things are altered
|FEBS Journal|2013|357
Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor
|Journal of Biological Chemistry|2004|145